A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)
Clinical trial NCT06701305 · COMPLETED
Trial details
- NCT number
- NCT06701305
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-13
- Primary completion
- 2025-02-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.